Add BrightSurf on Google Email

An Alzheimer's vaccine?

A new research study from Oklahoma Medical Research Foundation demonstrates that immunization could blunt or prevent Alzheimer's disease by targeting the build-up of protein plaques. The vaccinated mice showed a significant reduction in plaque accumulation and improved cognitive performance compared to control mice.

SourceOklahoma Medical Research Foundation·JournalThe FASEB Journal·DateNov 11, 2007

Internists endorse 2007-08 adult immunization schedule and publish in Annals of Internal Medicine

The American College of Physicians (ACP) has endorsed the 2007-08 adult immunization schedule, which recommends vaccination for varicella and zoster in adults. The CDC's adult immunization schedule aims to reduce vaccine-preventable deaths, with approximately 50,000 Americans dying each year from such diseases.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateOct 18, 2007

Hib vaccine: A critical ally in Asia's effort to reduce child deaths

A new study from Bangladesh found that routine Hib vaccination prevented over one-third of life-threatening pneumonia cases and approximately 90% of Hib meningitis cases. The vaccine has been shown to be a feasible and highly effective way of preventing death related to Hib pneumonia and meningitis in Asian children.

SourceThe Hib Initiative at Johns Hopkins Bloomberg School of Public Health·JournalThe Pediatric Infectious Disease Journal·DateJun 28, 2007

Progress toward an antitumor vaccine

Researchers at the University of Mainz have developed a novel approach to create antitumor vaccines by attaching tumor-associated glycopeptide antigens to a carrier protein via an immunocompatible thioether linkage. This method shows promise for inducing an immune response against cancer cells without irritating the immune system.

SourceWiley·DateJun 13, 2007

New study suggests potential for a broadly-protective HIV vaccine

Researchers at USU have developed a new HIV vaccine that induces broad-spectrum neutralizing antibodies, capable of neutralizing all 48 tested strains. The study provides encouraging results for vaccine development, showing the feasibility of eliciting cross-reactive antibodies against multiple viral strains.

SourceHenry M. Jackson Foundation for the Advancement of Military Medicine·JournalProceedings of the National Academy of Sciences·DateMay 29, 2007

Why Lincoln fell gravely ill after delivering his Gettysburg Address

A recent study suggests that President Abraham Lincoln was suffering from a life-threatening form of smallpox when he delivered his Gettysburg Address. Researchers compared clinical features of Lincoln's illness to those of smallpox and found a close match, suggesting he had contracted variola major, the more severe form of the disease.

SourceUniversity of Texas Medical Branch at Galveston·JournalJournal of Medical Biography·DateMay 17, 2007

Independent evaluation finds GAVI funding to poor countries can boost childhood vaccine coverage

A study found that GAVI funding significantly increased childhood vaccine coverage in countries with less than 65% initial coverage, raising it to around 65%. However, countries with higher initial coverage showed no improvement. The estimated cost per child immunized was under $14, close to GAVI's original estimates.

Europe slow to add infant pneumococcal vaccine to national programmes despite strong US results

Despite growing evidence, many European countries only vaccinate high-risk groups against infant pneumococcal disease (IPD), while the US adopted universal vaccination in 2000. Universal vaccination of infants and young children reduces risk and provides indirect herd protection for unvaccinated community members.

SourceBlackwell Publishing Ltd.·JournalInternational Journal of Clinical Practice·DateApr 10, 2006

Many foreign-born women in Miami are not vaccinated for rubella

A study found that only 11% of eligible foreign-born women in Miami received postpartum vaccinations, highlighting the need for increased vaccination efforts to prevent congenital rubella syndrome. The Centers for Disease Control and Prevention recommend vaccination for all women of childbearing age without evidence of rubella immunity.

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateFeb 7, 2006

Bank of America grant to expand community-based childhood immunization program in northern Manhattan

The Bank of America Charitable Foundation grant enables the Mailman School of Public Health's Northern Manhattan Start Right Coalition to scale up its community-based childhood immunization program. The program has seen a significant improvement in immunization rates, with an 80.5% current rate for children aged 19-35 months, exceeding...

New technique points to safer, more efficient vaccination

Researchers have developed a new approach that boosts the production of TAP, an immune system component, to make smaller vaccine doses more effective, reducing side effects and increasing immunization capacity. This technique has the potential to far-reaching benefits in the field of vaccines.

SourcePLOS·JournalPLOS Pathogens·DateDec 29, 2005

In wake of Lyme disease vaccine for people, mice may be next in line for shots

Researchers propose a novel approach to battling Lyme disease by vaccinating mice, which can reduce the number of infected ticks that transmit the disease. The study shows an overall 16% reduction in nymphal infection prevalence after immunizing mice, highlighting the potential of this method to combat Lyme disease.

SourceMichigan State University·JournalProceedings of the National Academy of Sciences·DateDec 13, 2004

VA increasing flu immunization rate

The study found that vaccinated elderly patients were 48% less likely to die during the 1998-99 season and 50% less likely to die during the 1999-2000 season. Additionally, vaccinated patients were less likely to develop pneumonia, cardiac disease, and stroke, confirming previous VA research on flu shots' life-saving benefits.

SourceVeterans Affairs Research Communications·JournalNew England Journal of Medicine·DateApr 2, 2003

Tool pinpoints acceptable pricing of combination vaccines

A new analysis tool developed by a University of Illinois researcher can help manufacturers determine the optimal price for combination vaccines. The tool considers various factors such as vaccine costs, individual and societal benefits, and consumer willingness to pay. By balancing these concerns, it aims to prevent overpayment by gov...

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalHealth Care Management Science·DateApr 8, 2002

Despite need for more shots, immunization

A study found that a new immunization regimen requiring up to four injections at one visit does not decrease vaccination rates despite increasing the risk of adverse reactions. The authors credit parental acceptance and safer vaccine versions for the sustained coverage levels.

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateNov 8, 2001